The Treatment for Adolescents With Depression Study (TADS): Outcomes Over 1 Year of Naturalistic Follow-Up

被引:104
作者
March, John
Silva, Susan
Curry, John
Wells, Karen
Fairbank, John
Burns, Barbara
Domino, Marisa
Vitiello, Benedetto
Severe, Joanne
Casat, Charles
Riedal, Karyn
Goldman, Marguerita
Feeny, Norah
Findling, Robert [1 ]
Stull, Sheridan [1 ]
Baab, Susan [1 ]
Weller, Elizabeth B. [2 ]
Robins, Michele [2 ]
Weller, Ronald A. [2 ]
Jessani, Naushad [2 ]
Waslick, Bruce [3 ]
Sweeney, Michael [3 ]
Dublin, Randi [3 ]
Walkup, John [4 ]
Ginsburg, Golda [4 ]
Kastelic, Elizabeth [4 ]
Koo, Hyung [4 ]
Kratochvil, Christopher [5 ]
May, Diane [5 ]
LaGrone, Randy [5 ]
Vaughan, Brigette [5 ]
Albano, Anne Marie [6 ]
Hirsch, Glenn S. [6 ]
Podniesinki, Elizabeth [6 ]
Chu, Angela [6 ]
Reinecke, Mark [7 ]
Leventhal, Bennett [7 ]
Rogers, Gregory [7 ]
Jacobs, Rachel [7 ]
Pathak, Sanjeev
Wells, Jennifer
Lavanier, Sarah A.
Danielyan, Arman
Rohde, Paul [8 ]
Simons, Anne [8 ]
Grimm, James [8 ]
Frank, Stephenie [8 ]
Emslie, Graham [9 ]
Kennard, Beth [9 ]
Hughes, Carroll [9 ]
机构
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
[2] Childrens Hosp Philadelphia, Philadelphia, PA USA
[3] Columbia Univ, New York, NY 10027 USA
[4] Johns Hopkins Univ, Baltimore, MD 21218 USA
[5] Univ Nebraska, Lincoln, NE 68583 USA
[6] NYU, New York, NY 10003 USA
[7] Northwestern Univ, Univ Chicago, Evanston, IL 60208 USA
[8] Univ Oregon, Eugene, OR 97403 USA
[9] Univ Texas SW Med Ctr Dallas, Dallas, TX USA
[10] Wayne State Univ, Detroit, MI 48202 USA
关键词
COGNITIVE-BEHAVIORAL THERAPY; MAJOR DEPRESSION; RELAPSE; TRIAL; PSYCHOTHERAPY; RECURRENCE; CHILDREN; PLACEBO; SAFETY; TIME;
D O I
10.1176/appi.ajp.2009.08111620
中图分类号
R749 [精神病学];
学科分类号
100204 [神经病学];
摘要
Objective: The Treatment for Adolescents With Depression Study ( TADS) evaluates the effectiveness of fluoxetine, cognitive-behavioral therapy (CBT), and their combination in adolescents with major depressive disorder. The authors report effectiveness outcomes across a 1-year naturalistic follow-up period. Method: The randomized, controlled trial was conducted in 13 academic and community sites in the United States. Stages I, II, and III consisted of 12, 6, and 18 weeks of acute, consolidation, and continuation treatment, respectively. Following discontinuation of TADS treatments at the end of stage III, stage IV consisted of 1 year of naturalistic follow-up. The participants were 327 subjects between the ages of 12 and 17 with a primary DSM-IV diagnosis of major depressive disorder. No TADS treatment was provided during the follow-up period; treatment was available in the community. The primary dependent measures, rated by an independent evaluator blind to treatment status, were the total score on the Children's Depression Rating Scale-Revised and the rate of response, defined as a rating of much or very much improved on the Clinical Global Impressions improvement measure. Results: Sixty-six percent of the eligible subjects participated in at least one stage IV assessment. The benefits seen at the end of active treatment ( week 36) persisted during follow-up on all measures of depression and suicidality. Conclusions: In contrast to earlier reports on short-term treatments, in which worsening after treatment is the rule, the longer treatment in the TADS was associated with persistent benefits over 1 year of naturalistic follow-up.
引用
收藏
页码:1141 / 1149
页数:9
相关论文
共 44 条
[1]
Turning darkness into light - A new landmark study on the treatment of adolescent depression. Comments on the TADS study [J].
Apter, A ;
Kronenberg, S ;
Brent, D .
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2005, 14 (03) :113-116
[2]
Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder [J].
Birmaher, B ;
Brent, DA ;
Kolko, D ;
Baugher, M ;
Bridge, J ;
Holder, D ;
Iyengar, S ;
Ulloa, RE .
ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (01) :29-36
[3]
A clinical trial for adolescent depression: Predictors of additional treatment in the acute and follow-up phases of the trial [J].
Brent, DA ;
Kolko, DJ ;
Birmaher, B ;
Baugher, M ;
Bridge, J .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1999, 38 (03) :263-270
[4]
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression - The TORDIA randomized controlled trial [J].
Brent, David ;
Emslie, Graham ;
Clarke, Greg ;
Wagner, Karen Dineen ;
Asarnow, Joan Rosenbaum ;
Keller, Marty ;
Vitiello, Benedetto ;
Ritz, Louise ;
Iyengar, Satish ;
Abebe, Kaleab ;
Birmaher, Boris ;
Ryan, Neal ;
Kennard, Betsy ;
Hughes, Carroll ;
DeBar, Lynn ;
McCracken, James ;
Strober, Michael ;
Suddath, Robert ;
Spirito, Anthony ;
Leonard, Henrietta ;
Melhem, Nadine ;
Porta, Giovanna ;
Onorato, Matthew ;
Zelazny, Jamie .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (08) :901-913
[5]
Glad for what TADS adds, but many TADS grads still sad [J].
Brent, David A. .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (12) :1461-1464
[6]
Cognitive-behavioral treatment of adolescent depression: Efficacy of acute group treatment and booster sessions [J].
Clarke, GN ;
Rohde, P ;
Lewinsohn, PM ;
Hops, H ;
Seeley, JR .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1999, 38 (03) :272-279
[7]
Striving for effectiveness in the treatment of adolescent depression: Cognitive behavior therapy for multisite community intervention [J].
Curry, JF ;
Wells, KC .
COGNITIVE AND BEHAVIORAL PRACTICE, 2005, 12 (02) :177-185
[8]
Relative Cost-Effectiveness of Treatments for Adolescent Depression: 36-Week Results From the TADS Randomized Trial [J].
Domino, Marisa Elena ;
Foster, E. Michael ;
Vitiello, Benedetto ;
Kratochvil, Christopher J. ;
Burns, Barbara J. ;
Silva, Susan G. ;
Reinecke, Mark A. ;
March, John S. .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2009, 48 (07) :711-720
[9]
Emslie G J, 1998, Depress Anxiety, V7, P32, DOI 10.1002/(SICI)1520-6394(1998)7:1<32::AID-DA4>3.0.CO
[10]
2-7